These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22665612)

  • 1. Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.
    Hutter J; Pasetti MF; Sanogo D; Tapia MD; Sow SO; Levine MM
    Am J Trop Med Hyg; 2012 Jun; 86(6):1026-31. PubMed ID: 22665612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
    Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
    Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
    Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
    Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
    Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
    Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
    Englund JA; Glezen WP; Thompson C; Anwaruddin R; Turner CS; Siber GR
    Pediatr Infect Dis J; 1997 Dec; 16(12):1122-30. PubMed ID: 9427456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
    Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study.
    Wagner AL; Sun X; Montgomery JP; Huang Z; Boulton ML
    PLoS One; 2014; 9(5):e97800. PubMed ID: 24828814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
    Zarei AE; Linjawi MH; Redwan EM
    Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Kurikka S; Käyhty H; Peltola H; Saarinen L; Eskola J; Mäkelä PH
    Pediatrics; 1995 Jun; 95(6):815-22. PubMed ID: 7761204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
    Ladhani SN
    Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.
    Capeding MR; Nohynek H; Käyhty H; Pascual LG; Sunico ES; Tamundong AA; Ruutu P
    Vaccine; 1998; 16(9-10):1004-8. PubMed ID: 9682351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.